Articles

The American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) have issued an updated consensus statement on the management of hyperglycemia in patients with type 2 diabetes.

In people without diabetes, A1C levels are positively associated with age, researchers report.

Rimonbant’s rough ride may be nearly over: today, the European Medicines Agency (EMEA) announced that it has recommended suspension of the weight-loss drug, marketed as Acomplia in Europe [1]. According to an EMEA committee, the benefits of the drug “no longer outweigh its risks.”

A new study has found no evidence that aspirin or antioxidants are of any benefit in the primary prevention of cardiovascular events in diabetic patients with asymptomatic peripheral arterial disease (PAD)

A combination of eating until full and eating quickly may increase the risk for overweight by 3-fold, according to the results of a cross-sectional survey. How an individual eats may be just as important as what he or she is eating.

Insulin provides better glycemic control and improvement in beta-cell function than do oral antidiabetes drugs in patients newly diagnosed with type 2 diabetes with severe hyperglycemia, according to a report in the October issue of Diabetes Care.

Investigators have completed the first of several international artificial pancreas clinical trials to test an individually-tailored, computerized system which automatically regulates a Type 1 diabetic patient’s blood glucose and insulin needs.

23 million Americans have diabetes, but 1-in-4 doesn’t know it yet. Burning, tingling or numbness in the feet and toes can be the first symptoms of diabetes, say physicians with the American College of Foot and Ankle Surgeons.

Outcome-based medicine, with comparison scores and monetary incentives, works for 14,000 diabetes patients at Montefiore Medical Center in the Bronx, NY. One standard measure of blood sugar, HbA1C, is kept below a recognized level of 9 in 85% of patients in the special program, vs 67-75% of patients in other …

After Inhaled insulin failed, we now have buccal, nasal, oral, inhaled and now rectal insulin in studies. Oramed Pharmaceuticals, Inc., a developer of alternative drug delivery systems, announced last week, that it has received approval from the South Africa Medicines Control Council to begin conducting Phase 1A trials on human …